• OPEN AN ACCOUNT
Indian Indices
Nifty
25,637.80 88.80
(0.35%)
Sensex
84,058.90 303.03
( 0.36%)
Bank Nifty
57,443.90 237.20
( 0.41%)
Nifty IT
38,822.95 -173.30
( -0.44%)
Global Indices
Nasdaq
43,834.06 426.21
(0.98%)
Dow Jones
6,192.89 30.87
(0.50%)
Hang Seng
40,056.27 471.69
(1.19%)
Nikkei 225
8,798.91 63.31
(0.72%)
Forex
USD-INR
85.73 -0.26
(-0.30%)
EUR-INR
100.32 0.36
(0.36%)
GBP-INR
117.66 0.46
(0.39%)
JPY-INR
0.59 0.00
(0.31%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5304659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
170.63
38.08
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

dalmia bharat sugar & industries ltd
NMDC iron ore production jumps 89% YoY in May’25
Jun 02,2025

While the company's iron ore sales increased 53.90% to 4.34 MT in May 2025, compared to 2.82 MT posted in May 2024.

Iron ore production in the Chhattisgarh division jumped 140.94% YoY to 3.06 MT in May 2025, while sales grew by 57.06% to 3.00 MT, compared to 1.91 MT in May 2024.

On the other hand, the Karnataka division saw a 28.03% YoY increase in production, reaching 1.37 MT in May 2025. Sales rose by 47.25% to 1.34 MT in May 2025, compared to 0.91 MT in May 2024.

NMDC is engaged in exploration and production of Iron Ore along with Diamond, production and sale of Sponge Iron and generation and sale of Wind Power.

The company’s consolidated net profit jumped 4.6% to Rs 1,477.68 crore on 7.9% rise in revenue from operations to Rs 7,004.59 crore in Q4 FY25 over Q4 FY24.

Shares of NMDC rose 0.25% to Rs 71.35 on the BSE.